Soru

Zorluk: OrtaPharmacologic Interventions

A 52-year-old woman presents to the outpatient clinic with a 2-day history of dysuria, urinary frequency, and suprapubic discomfort. She has a history of a mechanical mitral valve replacement for which she takes warfarin. Her most recent international normalized ratio (INR), checked 2 days ago, was 2.8. She has no fever, chills, vaginal discharge, or flank pain. Vital signs are temperature 37.1°C (98.8°F), heart rate 82/min, blood pressure 124/78 mm Hg, and respiratory rate 14/min. Physical examination reveals mild suprapubic tenderness but no costovertebral angle tenderness. Urinalysis shows positive leukocyte esterase, positive nitrites, and >50>50 white blood cells/hpf. She has no known drug allergies and her renal function is normal. Which of the following is the most appropriate pharmacologic management for this patient?

  1. Prescribe nitrofurantoin and continue the current warfarin doseCevap
  2. B
    Prescribe trimethoprim-sulfamethoxazole and continue the current warfarin dose
  3. C
    Prescribe amoxicillin and continue the current warfarin dose
  4. D
    Prescribe nitrofurantoin and administer low-dose oral vitamin K
  5. E
    Prescribe nitrofurantoin and switch warfarin to apixaban

Cevap

Prescribe nitrofurantoin and continue the current warfarin dose
The correct intervention is to prescribe nitrofurantoin and continue the current warfarin dose. This patient is presenting with symptoms and urinalysis findings classic for an uncomplicated urinary tract infection (cystitis). Nitrofurantoin, fosfomycin, and trimethoprim-sulfamethoxazole (TMP-SMX) are traditional first-line agents for this condition. However, because this patient is taking warfarin for a mechanical mitral valve, antibiotic selection must carefully avoid drug-drug interactions. Nitrofurantoin is an excellent choice as it provides effective empiric coverage for uropathogens like *Escherichia coli* and does not interact with warfarin metabolism. Furthermore, the patient's INR of 2.82.8 is within the ideal therapeutic range (2.5−3.52.5 - 3.5) for a mechanical mitral valve. Therefore, no adjustment to her warfarin dose is necessary.

Adım Adım Çözüm

1
Diagnose the patient's acute presentation based on clinical and laboratory findings.
The patient has acute uncomplicated cystitis (urinary tract infection), indicated by classic lower urinary tract symptoms and a positive urinalysis without systemic signs.
Establishing the correct diagnosis dictates the need for targeted empiric antibiotic therapy.
2
Evaluate the patient's comorbidities and current medications for potential interactions.
The patient is taking warfarin for a mechanical mitral valve. Her target INR is 2.5−3.52.5 - 3.5, making her current INR of 2.82.8 therapeutic.
Patients with mechanical valves require strict anticoagulation. Any new medication must be heavily screened for interactions that could alter warfarin metabolism.
3
Select the most appropriate antibiotic that effectively treats the infection while avoiding significant pharmacokinetic interactions.
Nitrofurantoin is selected because it is a first-line agent for uncomplicated cystitis and does not inhibit the cytochrome P450 system.
Other common UTI antibiotics, such as trimethoprim-sulfamethoxazole and fluoroquinolones, interact with warfarin and drastically increase the risk of bleeding.

Anahtar Kavram

In patients stabilized on warfarin, empiric antibiotic selection for uncomplicated infections must avoid strong CYP450 inhibitors (like trimethoprim-sulfamethoxazole) to prevent dangerous elevations in INR and bleeding risk.
Bu soruyu puanla